P.P. Power

1.7k total citations
58 papers, 997 citations indexed

About

P.P. Power is a scholar working on Molecular Medicine, Endocrinology and Molecular Biology. According to data from OpenAlex, P.P. Power has authored 58 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Medicine, 22 papers in Endocrinology and 16 papers in Molecular Biology. Recurrent topics in P.P. Power's work include Antibiotic Resistance in Bacteria (48 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Bacterial biofilms and quorum sensing (12 papers). P.P. Power is often cited by papers focused on Antibiotic Resistance in Bacteria (48 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers) and Bacterial biofilms and quorum sensing (12 papers). P.P. Power collaborates with scholars based in Argentina, Belgium and United States. P.P. Power's co-authors include Gabriel Gutkind, Juan A. Ayala, Marcela Rádice, Moreno Galleni, José Di Conza, M.M. Rodríguez, Marta Mollerach, Carlos Vay, Àngela Famiglietti and Cristina González and has published in prestigious journals such as PLoS ONE, Biochemistry and Journal of Clinical Microbiology.

In The Last Decade

P.P. Power

54 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.P. Power Argentina 18 723 371 286 180 171 58 997
José Di Conza Argentina 17 655 0.9× 352 0.9× 175 0.6× 235 1.3× 139 0.8× 66 926
Lizhang Liu China 14 956 1.3× 391 1.1× 178 0.6× 284 1.6× 212 1.2× 21 1.1k
Fernando Corona Spain 14 595 0.8× 210 0.6× 542 1.9× 272 1.5× 116 0.7× 20 1.2k
Ya-Hong Liu China 15 589 0.8× 245 0.7× 199 0.7× 242 1.3× 85 0.5× 20 788
Vijaya Bharathi Srinivasan India 14 705 1.0× 298 0.8× 336 1.2× 192 1.1× 169 1.0× 19 899
Amitabha Bhattacharjee India 20 753 1.0× 306 0.8× 309 1.1× 265 1.5× 169 1.0× 96 1.0k
Manuel Alcalde‐Rico Spain 13 740 1.0× 184 0.5× 587 2.1× 264 1.5× 169 1.0× 28 1.2k
Cristina Lagatolla Italy 17 457 0.6× 226 0.6× 427 1.5× 96 0.5× 72 0.4× 49 892
Xuan Wang‐Kan United Kingdom 7 518 0.7× 147 0.4× 382 1.3× 112 0.6× 145 0.8× 7 930
Maria Giannouli Italy 14 1.1k 1.6× 680 1.8× 460 1.6× 180 1.0× 260 1.5× 17 1.3k

Countries citing papers authored by P.P. Power

Since Specialization
Citations

This map shows the geographic impact of P.P. Power's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.P. Power with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.P. Power more than expected).

Fields of papers citing papers by P.P. Power

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.P. Power. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.P. Power. The network helps show where P.P. Power may publish in the future.

Co-authorship network of co-authors of P.P. Power

This figure shows the co-authorship network connecting the top 25 collaborators of P.P. Power. A scholar is included among the top collaborators of P.P. Power based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.P. Power. P.P. Power is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gutkind, Gabriel, et al.. (2025). Impact of the double deletion ΔG242-T243 in KPC-2 in the effectiveness of ceftazidime-avibactam and imipenem-relebactam. Antimicrobial Agents and Chemotherapy. 69(6). e0191524–e0191524.
3.
Gutkind, Gabriel, et al.. (2024). Insights into the activity of cefiderocol against PER-2 producing Enterobacterales. Antimicrobial Agents and Chemotherapy. 68(6). e0172023–e0172023. 1 indexed citations
4.
Rodríguez, M.M., Christopher R. Bethel, Gabriel Gutkind, et al.. (2024). Crystal structure of the class A extended-spectrum β-lactamase CTX-M-96 in complex with relebactam at 1.03 Angstrom resolution. Antimicrobial Agents and Chemotherapy. 68(8). e0172123–e0172123. 2 indexed citations
5.
Gutkind, Gabriel, et al.. (2024). Genetic and Biochemical Characterization of AXC-2 from Achromobacter ruhlandii. Pathogens. 13(2). 115–115. 2 indexed citations
6.
Rodríguez, M.M., Magdalena A. Taracila, María F. Mojica, et al.. (2023). Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses. Antimicrobial Agents and Chemotherapy. 67(1). e0093022–e0093022. 6 indexed citations
7.
Torres, Carolina, et al.. (2021). Diversity of β-lactamase-encoding genes in wastewater: bacteriophages as reporters. Archives of Virology. 166(5). 1337–1344. 9 indexed citations
8.
Rodríguez, M.M., Krisztina M. Papp‐Wallace, Ayumi Yoshizumi, et al.. (2021). Structural and Biochemical Characterization of the Novel CTX-M-151 Extended-Spectrum β-Lactamase and Its Inhibition by Avibactam. Antimicrobial Agents and Chemotherapy. 65(4). 7 indexed citations
9.
Conza, José Di, María Tereza Pepe Razzolini, Bruna Fuga, et al.. (2021). Characterization of Emerging Pathogens Carrying blaKPC-2 Gene in IncP-6 Plasmids Isolated From Urban Sewage in Argentina. Frontiers in Cellular and Infection Microbiology. 11. 722536–722536. 16 indexed citations
10.
Fuentes‐Castillo, Danny, P.P. Power, Louise Cerdeira, et al.. (2020). FONA-7, a Novel Extended-Spectrum β-Lactamase Variant of the FONA Family Identified in Serratia fonticola. Microbial Drug Resistance. 27(5). 585–589. 6 indexed citations
11.
Rodríguez, M.M., R. Herman, Frédéric Kerff, et al.. (2017). Crystal structure and kinetic analysis of the class B3 di-zinc metallo-β-lactamase LRA-12 from an Alaskan soil metagenome. PLoS ONE. 12(7). e0182043–e0182043. 11 indexed citations
12.
Sauvage, E., et al.. (2017). Impact of Mutations at Arg220 and Thr237 in PER-2 β-Lactamase on Conformation, Activity, and Susceptibility to Inhibitors. Antimicrobial Agents and Chemotherapy. 61(6). 11 indexed citations
13.
Ramírez, Ana S., Ángel Cataldi, Gabriel Gutkind, et al.. (2016). Biochemical Characterization of β-Lactamases from Mycobacterium abscessus Complex and Genetic Environment of the β-Lactamase-Encoding Gene. Microbial Drug Resistance. 23(3). 294–300. 10 indexed citations
15.
Gutkind, Gabriel, José Di Conza, P.P. Power, & Marcela Rádice. (2012). β-lactamase-mediated Resistance: A Biochemical, Epidemiological and Genetic Overview. Current Pharmaceutical Design. 19(2). 164–208. 9 indexed citations
16.
Power, P.P., Paola Sandra Mercuri, R. Herman, et al.. (2012). Novel fragments of clavulanate observed in the structure of the class A  -lactamase from Bacillus licheniformis BS3. Journal of Antimicrobial Chemotherapy. 67(10). 2379–2387. 6 indexed citations
17.
Mercuri, Paola Sandra, et al.. (2011). Emergence and Dominance of CTX-M-15 Extended Spectrum Beta-Lactamase Among Escherichia coli Isolates from Children. Microbial Drug Resistance. 17(2). 135–140. 12 indexed citations
18.
Mercuri, Paola Sandra, et al.. (2008). First detection of CTX-M-28 in a Tunisian hospital from a cefotaxime-resistant Klebsiella pneumoniae strain. Pathologie Biologie. 57(5). 343–348. 20 indexed citations
19.
Rodríguez, M.M., P.P. Power, Cédric Bauvois, et al.. (2006). Characterisation of KLUA-9, a β-lactamase from extended-spectrum cephalosporin-susceptible Kluyvera ascorbata, and genetic organisation of blaKLUA-9. International Journal of Antimicrobial Agents. 29(3). 332–337. 3 indexed citations
20.
Power, P.P., Marta Mollerach, Gabriel Gutkind, et al.. (1999). Cefotaxime-Hydrolysing Beta Lactamases in Morganella morganii. European Journal of Clinical Microbiology & Infectious Diseases. 18(10). 743–747. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026